<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Common diseases such as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are phenotypically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> is a major risk factor for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, but patients vary appreciably in body mass index </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that the genetic predisposition to the disease may be different in lean (BMI&lt;25 Kg/m²) compared to <z:mp ids='MP_0001261'>obese</z:mp> cases (BMI≥30 Kg/m²) </plain></SENT>
<SENT sid="3" pm="."><plain>We performed two case-control genome-wide studies using two accepted cut-offs for defining individuals as overweight or <z:mp ids='MP_0001261'>obese</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>We used 2,112 lean type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> cases (BMI&lt;25 kg/m²) or 4,123 <z:mp ids='MP_0001261'>obese</z:mp> cases (BMI≥30 kg/m²), and 54,412 un-stratified controls </plain></SENT>
<SENT sid="5" pm="."><plain>Replication was performed in 2,881 lean cases or 8,702 <z:mp ids='MP_0001261'>obese</z:mp> cases, and 18,957 un-stratified controls </plain></SENT>
<SENT sid="6" pm="."><plain>To assess the effects of known signals, we tested the individual and combined effects of SNPs representing 36 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> loci </plain></SENT>
<SENT sid="7" pm="."><plain>After combining data from discovery and replication datasets, we identified two signals not previously reported in Europeans </plain></SENT>
<SENT sid="8" pm="."><plain>A variant (rs8090011) in the LAMA1 gene was associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in lean cases (P = 8.4×10⁻⁹, OR = 1.13 [95% CI 1.09-1.18]), and this association was stronger than that in <z:mp ids='MP_0001261'>obese</z:mp> cases (P = 0.04, OR = 1.03 [95% CI 1.00-1.06]) </plain></SENT>
<SENT sid="9" pm="."><plain>A variant in HMG20A--previously identified in South Asians but not Europeans--was associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in <z:mp ids='MP_0001261'>obese</z:mp> cases (P = 1.3×10⁻⁸, OR = 1.11 [95% CI 1.07-1.15]), although this association was not significantly stronger than that in lean cases (P = 0.02, OR = 1.09 [95% CI 1.02-1.17]) </plain></SENT>
<SENT sid="10" pm="."><plain>For 36 known type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> loci, 29 had a larger odds ratio in the lean compared to <z:mp ids='MP_0001261'>obese</z:mp> (binomial P = 0.0002) </plain></SENT>
<SENT sid="11" pm="."><plain>In the lean analysis, we observed a weighted per-risk allele OR = 1.13 [95% CI 1.10-1.17], P = 3.2×10⁻¹⁴ </plain></SENT>
<SENT sid="12" pm="."><plain>This was larger than the same model fitted in the <z:mp ids='MP_0001261'>obese</z:mp> analysis where the OR = 1.06 [95% CI 1.05-1.08], P = 2.2×10⁻¹⁶ </plain></SENT>
<SENT sid="13" pm="."><plain>This study provides evidence that stratification of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> cases by BMI may help identify additional risk variants and that lean cases may have a stronger genetic predisposition to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>